In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

John Arena is interim president of global pharma services at Cencora, managing a team that offers a broad range of solutions ...

By embracing biohacking trends strategically and ethically, brands can position themselves as leaders in the wellness ...

Today, Uncle Sam’s foot is almost exclusively stomping on emerging biotechnology’s brakes, is only tepidly engaged with the accelerator, and is still hands off the wheel. A new Congress and ...

Sears noted that small and emerging biotechnology companies have been at the forefront of this innovation. In 2023, approximately two-thirds of all clinical trials were initiated by small and ...

The pharma will acquire Araris Biotech to gain access to three preclinical ADCs and a linking technology Araris claims is ...

describing Siegall as “a highly passionate and effective leader with a demonstrated ability to build significant value for an emerging biotechnology company.” The new biotech’s chairman ...

Strategic investments in emerging biotech companies offer long-term upside, but also expose Innoviva to volatile swings in valuation that could compromise financial stability. Continuing to invest ...